VedaBio Expands CRISPR-Based Molecular Detection Platform With Mammoth Biosciences’ Technology
SAN DIEGO & BRISBANE, Calif.–(BUSINESS WIRE)–VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive... Read more.
Horizon Quantum to Go Public in the U.S. Through Definitive Business Combination Agreement with dMY Squared Technology Group
Transaction expected to significantly accelerate Horizon Quantum’s development of the software infrastructure to power the future of quantum computing Transaction... Read more.
Sverica Capital Management Announces Strategic Growth Investment in Raken
SAN FRANCISCO–(BUSINESS WIRE)–Sverica Capital Management LP (“Sverica”), a private equity investment firm, announced today that it has made a strategic... Read more.
Windjammer Capital Acquires PDU Cables and EPCO
A leading builder of custom power cable solutions for data centers NEWPORT BEACH, Calif. & WALTHAM, Mass.–(BUSINESS WIRE)–Windjammer Capital (“Windjammer”),... Read more.
Omdia Forecasts Display Driver IC Shipments to Dip 2% Before Rebound in 2026
LONDON–(BUSINESS WIRE)–#Consumer–Global shipments for Display Driver ICs (DDICs) are projected to experience a 2% year-on-year (YoY) decline in... Read more.
Celebrating Public Sector Innovation: Euna Solutions Announces Winners of 2025 Euna Impact Awards
New awards program honors public sector leaders driving innovation, transparency and community impact across North America ATLANTA & TORONTO–(BUSINESS... Read more.
LGC Group Opens $100M Organic Chemistry Synthesis Centre of Excellence in Vaughan, Strengthening Canada’s Role in Global Life Sciences
VAUGHAN, Ontario–(BUSINESS WIRE)–LGC Group, a global leader in life sciences, today officially opened its new Organic Chemistry Synthesis Centre of Excellence... Read more.
Hudson Labs Launches Co-Analyst — High-Precision AI for Institutional Equity Research
TORONTO–(BUSINESS WIRE)–Hudson Labs Announces Launch of Co-Analyst AI Platform Hudson Labs, a financial AI company founded in 2019, today announced the... Read more.
Abdera Therapeutics Presents Initial Phase 1 Clinical Data on ABD-147, a Next-generation DLL3-targeting Radiopharmaceutical Therapy, at IASLC 2025 World Conference on Lung Cancer
Data from first patient cohort provide human proof-of-concept and support continued dose escalation in patients with small cell lung cancer and large cell neuroendocrine... Read more.
Incubeta Acquires RocketSource to Expand Human-Centered AI Capabilities
Acquisition expands Incubeta’s AI offerings, combining behavioral science and performance expertise to help marketers drive sustainable growth LONDON–(BUSINESS... Read more.